Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs

NCT05230654 is registered in ClinicalTrials.gov with Shanghai Children's Medical Center as lead sponsor.

NCT NCT05230654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05230654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs
Lead sponsor
Shanghai Children's Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2022
Completion date
May 1, 2022
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced nausea and vomiting pediatric cancer patients